Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07528469

The Effects of PeptiStrong and Whey on Muscle Function In Older Adults

The Effects of PeptiStrong and Low Dose Whey Protein Versus High Dose Whey Protein Alone on Muscle Function In Older Adults

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Nuritas Ltd · Industry
Sex
All
Age
60 Years – 85 Years
Healthy volunteers
Accepted

Summary

Examining the effects of PeptiStrong and protein on muscle function in older adults

Detailed description

The aim of this study is to compare two protein drinks containing whey protein (derived from milk) in healthy adults aged 60 to 85 years. One group will consume a standard whey protein drink (20g), while the other group will consume a drink with half the total protein dose (10g) made of whey protein and PeptiStrong, a fava bean hydrolysate containing bioactive peptides. The study will assess whether the lower protein drink containing PeptiStrong will lead to equal or greater improvements than the standard drink in physical function, such as the ability to stand up from a chair, walk at a normal pace, maintain balance, and grip strength. The study will also examine markers related to inflammation, fatigue, and quality of life. The intended value of this research is to improve understanding of how targeted nutritional strategies may help maintain or improve muscle function in older adults. The findings may help inform future nutritional recommendations and the development of practical dietary interventions aimed at supporting healthy ageing and independence.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPeptiStrong + whey proteinFava bean protein hydrolysate containing bioactive peptides mixed with whey protein as dry powder for drinkable protein shake
DIETARY_SUPPLEMENTWhey proteinWhey protein as dry powder for drinkable protein shake

Timeline

Start date
2026-04-06
Primary completion
2026-07-30
Completion
2026-10-30
First posted
2026-04-14
Last updated
2026-04-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07528469. Inclusion in this directory is not an endorsement.